Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

November 01, 2005 (Vol. 25, No. 19)

Challenges Remain for Antibody Products

Roadblocks Serve as Powerful Drivers for Complex Technology

  • Despite the fact that monoclonal antibody technology celebrates its 30th birthday this year, its movement into adulthood has not brought a serene and settled maturity. "Going forward is difficult," according to Richard Siegel, Ph.D., vp for pharmaceutical development at Centocor (Malvern, PA). The introduction of OKT3 in 1985, ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.